Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 359

1.
2.

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

Bacigalupo A, Lamparelli T, Bruzzi P, Guidi S, Alessandrino PE, di Bartolomeo P, Oneto R, Bruno B, Barbanti M, Sacchi N, Van Lint MT, Bosi A.

Blood. 2001 Nov 15;98(10):2942-7.

PMID:
11698275
[PubMed - indexed for MEDLINE]
Free Article
3.

ATG plus corticosteroid therapy for acute graft-versus-host disease: predictors of response and survival.

Dugan MJ, DeFor TE, Steinbuch M, Filipovich AH, Weisdorf DJ.

Ann Hematol. 1997 Jul-Aug;75(1-2):41-6. Review.

PMID:
9322682
[PubMed - indexed for MEDLINE]
4.

Graft-versus-host disease prophylaxis with anti-T-cell monoclonal antibody OKT3, prednisone and methotrexate in allogeneic bone-marrow transplantation.

Filipovich AH, Krawczak CL, Kersey JH, McGlave P, Ramsay NK, Goldman A, Goldstein G.

Br J Haematol. 1985 May;60(1):143-52.

PMID:
3890926
[PubMed - indexed for MEDLINE]
5.

Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone.

Deeg HJ, Loughran TP Jr, Storb R, Kennedy MS, Sullivan KM, Doney K, Appelbaum FR, Thomas ED.

Transplantation. 1985 Aug;40(2):162-6.

PMID:
3895622
[PubMed - indexed for MEDLINE]
6.

Marrow transplant experience for children with severe aplastic anemia.

Sanders JE, Storb R, Anasetti C, Deeg HJ, Doney K, Sullivan KM, Witherspoon RP, Hansen J.

Am J Pediatr Hematol Oncol. 1994 Feb;16(1):43-9.

PMID:
8311172
[PubMed - indexed for MEDLINE]
7.

Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia.

Storb R, Etzioni R, Anasetti C, Appelbaum FR, Buckner CD, Bensinger W, Bryant E, Clift R, Deeg HJ, Doney K, et al.

Blood. 1994 Aug 1;84(3):941-9.

PMID:
8043876
[PubMed - indexed for MEDLINE]
Free Article
8.

What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?

Storb R, Pepe M, Anasetti C, Appelbaum FR, Beatty P, Doney K, Martin P, Stewart P, Sullivan KM, Witherspoon R, et al.

Blood. 1990 Sep 1;76(5):1037-45.

PMID:
2203481
[PubMed - indexed for MEDLINE]
Free Article
9.

Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation.

Grosskreutz C, Ross V, Scigliano E, Fruchtman S, Isola L.

Biol Blood Marrow Transplant. 2003 Jul;9(7):453-9.

PMID:
12869959
[PubMed - indexed for MEDLINE]
10.

Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.

Zakerinia M, Khojasteh HN, Ramzi M, Haghshenas M.

Transplant Proc. 2005 Dec;37(10):4477-81.

PMID:
16387149
[PubMed - indexed for MEDLINE]
11.

Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment.

Witherspoon RP, Storb R, Ochs HD, Fluornoy N, Kopecky KJ, Sullivan KM, Deeg JH, Sosa R, Noel DR, Atkinson K, Thomas ED.

Blood. 1981 Aug;58(2):360-8.

PMID:
6454452
[PubMed - indexed for MEDLINE]
Free Article
12.

Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.

Bacigalupo A, Lamparelli T, Barisione G, Bruzzi P, Guidi S, Alessandrino PE, di Bartolomeo P, Oneto R, Bruno B, Sacchi N, van Lint MT, Bosi A; Gruppo Italiano Trapianti Midollo Osseo (GITMO).

Biol Blood Marrow Transplant. 2006 May;12(5):560-5.

PMID:
16635791
[PubMed - indexed for MEDLINE]
13.

Treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Randomized study comparing corticosteroids and cyclosporine.

Kennedy MS, Deeg HJ, Storb R, Doney K, Sullivan KM, Witherspoon RP, Appelbaum FR, Stewart P, Sanders J, Buckner CD, et al.

Am J Med. 1985 Jun;78(6 Pt 1):978-83.

PMID:
3893112
[PubMed - indexed for MEDLINE]
14.

Treatment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation.

Crump M, Larratt LM, Maki E, Curtis JE, Minden MD, Meharchand JM, Lipton JH, Messner HA.

Am J Med. 1992 Jun;92(6):596-602.

PMID:
1605140
[PubMed - indexed for MEDLINE]
15.

Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle.

Storb R, Thomas ED, Weiden PL, Buckner CD, Clift RA, Fefer A, Fernando LP, Giblett ER, Goodell BW, Johnson FL, Lerner KG, Neiman PE, Sanders JE.

Blood. 1976 Dec;48(6):817-41.

PMID:
11859
[PubMed - indexed for MEDLINE]
Free Article
16.

Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin.

McCaul KG, Nevill TJ, Barnett MJ, Toze CL, Currie CJ, Sutherland HJ, Conneally EA, Shepherd JD, Nantel SH, Hogge DE, Klingemann HG.

J Hematother Stem Cell Res. 2000 Jun;9(3):367-74.

PMID:
10894358
[PubMed - indexed for MEDLINE]
17.

Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial.

Locatelli F, Bruno B, Zecca M, Van-Lint MT, McCann S, Arcese W, Dallorso S, Di Bartolomeo P, Fagioli F, Locasciulli A, Lawler M, Bacigalupo A.

Blood. 2000 Sep 1;96(5):1690-7.

PMID:
10961865
[PubMed - indexed for MEDLINE]
Free Article
18.

[Clinical trial of antithymocyte globulin for prophylaxis of acute graft-versus-host disease in pediatric recipients of bone marrow transplantation from unrelated donors].

Yagasaki H, Kojima S, Inaba J, Kato K, Matsuyama T.

Rinsho Ketsueki. 1999 May;40(5):382-9. Japanese.

PMID:
10390886
[PubMed - indexed for MEDLINE]
19.

Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.

Ratanatharathorn V, Nash RA, Przepiorka D, Devine SM, Klein JL, Weisdorf D, Fay JW, Nademanee A, Antin JH, Christiansen NP, van der Jagt R, Herzig RH, Litzow MR, Wolff SN, Longo WL, Petersen FB, Karanes C, Avalos B, Storb R, Buell DN, Maher RM, Fitzsimmons WE, Wingard JR.

Blood. 1998 Oct 1;92(7):2303-14.

PMID:
9746768
[PubMed - indexed for MEDLINE]
Free Article
20.

A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.

Winston DJ, Antin JH, Wolff SN, Bierer BE, Small T, Miller KB, Linker C, Kaizer H, Lazarus HM, Petersen FB, Cowan MJ, Ho WG, Wingard JR, Schiller GJ, Territo MC, Jiao J, Petrarca MA, Tonetta SA.

Bone Marrow Transplant. 2001 Jul;28(2):187-96.

PMID:
11509937
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk